Quick Overview: Dealmaking by a pair of pharmas has given the biotech industry Srikala Sridhar, MD, FRCPC, Princess Margaret Cancer Centre, Toronto, ON, provides a summary of her key highlights from ... Send us Fan Mail ( Imagine having the latest breakthroughs in oncology from ...

Ep 301 Asco S First - Detailed Overview & Context

Dealmaking by a pair of pharmas has given the biotech industry Srikala Sridhar, MD, FRCPC, Princess Margaret Cancer Centre, Toronto, ON, provides a summary of her key highlights from ... Send us Fan Mail ( Imagine having the latest breakthroughs in oncology from ...

Photo Gallery

Ep. 301 - ASCO’s First-in-Human Trials, Crossover Investors & FDA's Rare Disease Plans
Ep. 300 - Biotech’s $13B Deal Day, ASCO's Hot Targets, Drug Pricing Threat
EP #301
CheckMate 274 & EV-301: highlights in UC from ASCO GU
Systemic Therapy for SCLC: ASCO-OH (CCO) Guideline
Ep. 86 – Macrophages, ASCO & Clever-1: Faron CEO Juho Jalkanen on Bexmarilimab’s Promise
Cresta Block A unit 301
The OJC Episode 6: ASCO 2024 Special Part 1
Best of Lung Cancer Science - American Society of Clinical Oncology (ASCO)
Ep. 86 – Macrophages, ASCO & Clever-1: Faron CEO Juho Jalkanen on Bexmarilimab’s Promise
70th and Final Episode of F1 Masters, For Now
SFA Education Session: ASCO Review 2024
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored